Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Maze Therapeutics, Inc. | StockGist | StockGist

Companies
MAZE
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings MAZESCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Maze Therapeutics, Inc.

Filed May 15, 2025

Accepted May 14, 2025, 8:00 PM ET

CIK 0001842295

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

10

Reporting Person

Maze Therapeutics, Inc.

Person Type

PN

CUSIP: 578784100

Amendment History

6 filings

SCHEDULE 13G
Original
Viewing
May 15, 20250001072613-25-000407
SCHEDULE 13G/A
Amendment 1
Aug 14, 20250001172661-25-003264
SCHEDULE 13G/A
Amendment 2
Aug 14, 20250001274173-25-000250
SCHEDULE 13G/A
Amendment 3
Aug 14, 20250001415889-25-021795
SCHEDULE 13G/A
Amendment 4
Feb 13, 20260001193125-26-051800
SCHEDULE 13G/A
Amendment 5
Latest
Feb 13, 20260001231919-26-000147

Key Facts

Shares Owned

10

Recent Filings

Maze Therapeutics, Inc.1 weeks ago

Maze Therapeutics, Inc.1 weeks ago

Maze Therapeutics, Inc.1 months ago

Maze Therapeutics, Inc.1 months ago

Maze Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice